ANIK
Anika Therapeutics Inc
20.40$
-2.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.8% | 22.6% | 23.2% | 24.1% | 29.6% | 25.1% | 47.1% | 43.9% | 40.1% | 31.7% | 36.6% | 43.4% | |
| 80.2% | 77.4% | 76.8% | 75.9% | 70.4% | 74.9% | 52.9% | 56.1% | 59.9% | 68.3% | 63.4% | 56.6% | |
| 7.7% | 9.7% | 10.4% | 16.6% | 17.2% | 14.5% | 18.0% | 18.5% | 18.0% | 18.0% | 21.3% | 22.8% | |
| 14.3% | 15.9% | 17.4% | 19.0% | 32.5% | 30.5% | 46.0% | 35.9% | 54.3% | 81.6% | 46.3% | 43.5% | |
| 22.0% | 25.6% | 27.8% | 35.6% | 49.8% | 45.0% | 74.6% | 54.4% | 72.3% | 67.6% | 67.6% | 66.4% | |
| 58.2% | 51.8% | 49.0% | 40.3% | 20.6% | 29.9% | -21.7% | 1.8% | -12.4% | 0.7% | -4.3% | -9.8% | |
| 0.1% | 0.1% | 0.3% | 0.4% | 1.4% | 6.9% | 0.6% | 0.1% | 0.4% | 1.9% | 1.9% | 1.5% | |
| 58.2% | 51.9% | 49.2% | 40.7% | 22.0% | 31.5% | -21.9% | 1.6% | -12.0% | 2.6% | -2.3% | -8.2% | |
| 22.0% | 18.8% | 17.7% | 12.7% | 4.2% | 7.8% | -3.6% | -1.2% | -2.5% | 5.5% | 5.1% | 0.6% | |
| 36.3% | 33.1% | 31.5% | 28.1% | 17.7% | 23.7% | -18.4% | 2.8% | -9.5% | -68.4% | -47.0% | -9.6% | |
| 62.6% | 55.8% | 52.6% | 44.1% | 26.2% | 35.1% | -0.8% | -2.8% | -3.1% | 14.4% | 4.5% | -3.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.